Therapeutics

Ripple Therapeutics Research on Polymer-Free Drug Delivery Published in Nature Communications

Ripple Therapeutics Research on Polymer-Free Drug Delivery Published in Nature Communications

Ripple Therapeutics Research on Polymer-Free Drug Delivery Published in Nature Communications

wolf2021 9. June 2021

[ad_1] TORONTO, ON / ACCESSWIRE / June 1, 2021 / Ripple Therapeutics Corporation (“Ripple”), a clinical stage,...

Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors

Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors

Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors

wolf2021 4. May 2021

[ad_1] TORONTO, ON / ACCESSWIRE / May 4, 2021 / Ripple Therapeutics Corporation (‘Ripple’) a clinical stage,...

Ripple Therapeutics Announces First Patient Treated in Phase II Trial Evaluating IBE-814 IVT in DME and RVO

Ripple Therapeutics Research on Polymer-Free Drug Delivery Published in Nature Communications

Ripple Therapeutics Announces First Patient Treated in Phase II Trial Evaluating IBE-814 IVT in DME and RVO

wolf2021 21. April 2021

[ad_1] Bloomberg China’s $87 Billion Electric-Car Giant Hasn’t Sold a Vehicle Yet (Bloomberg) — China Evergrande New...